Hjem › Aterosklerose › North Carolina
Kliniske studier for Aterosklerose i North Carolina
12 studier for Aterosklerose søker deltakere på steder i North Carolina.
Byer i North Carolina
Offisiell studietekst (engelsk)
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
- UNC Heart & Vascular, Chapel Hill
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT07448038Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- Care Access - Fayetteville, Fayetteville
- Medication Management, Greensboro
- Monroe Biomedical Research, Monroe
- og 1 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 24. sep. 2026 · NCT07157774Study of the Effect of Innate on the Inflammatory Response to Endotoxin
- NIEHS Clinical Research Unit (CRU), Research Triangle Park
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 18 til 100 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT01143480Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Novant Health Heart and Vascular Institute, Charlotte
- Velocity Clinical Research - Durham, Durham
- Moses H Cone Memorial Hospital, Greensboro
- og 7 flere
RekruttererFase 3
Alder 45 til 99 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07037433A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
- NC Heart and Vascular Research, LLC, Raleigh
- Javara Inc. - Wake Forest University Health Sciences, Winston-Salem
RekruttererFase 2
Alder 18 til 80 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07521007Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Metrolina Nephrology Associates, PA, Charlotte
- Durham Nephrology Associates, PA, Durham
- Duke Translational Medicine Institute, Durham
- og 3 flere
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 21. sep. 2026 · NCT05485961A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Asheville
- Research Site, Chapel Hill
- Research Site, Charlotte
- og 11 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 24. aug. 2026 · NCT07000357Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
- Wake Forest University Baptist Medical Center, Winston-Salem
RekruttererFase 3
Alder 18 til 80 · Alle kjønn · Oppdatert 7. aug. 2026 · NCT06813911Pelacarsen Roll-over Extension Program
- Monroe Biomedical Research, Monroe
- Alliance Medical Ministry, Raleigh
RekruttererFase 3
Alder 18 til 100 · Alle kjønn · Oppdatert 29. jul. 2026 · NCT06875973Pharmacogenomic Informed Statin Prescribing
- Durham VA Medical Center, Durham, NC, Durham
Rekrutterer
Alder 40 til 75 · Alle kjønn · Oppdatert 13. apr. 2026 · NCT06568601Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial
- Wake Forest University Health Sciences, Winston-Salem
RekruttererFase 2
Alder 40 til 75 · Alle kjønn · Oppdatert 27. feb. 2026 · NCT06488105Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
- Durham VA Medical Center, Durham, NC, Durham
RekruttererFase 4
Alder 18 og eldre · Alle kjønn · Oppdatert 17. des. 2025 · NCT02915198Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.